Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation

Tests for mutations in the DPD gene, which is responsible for metabolizing certain chemotherapy drugs. This test helps guide safe drug dosing.

Also known asDPD Gene MutationDPYD TestDihydropyrimidine Dehydrogenase Test5-FU Toxicity Gene Test

Available via

Home Collection, Lab Visit

Contains

2 parameters

Earliest reports in

7 Working Days

Test details

Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation Test in New Delhi Overview

Preparations

No special preparations needed

Test included
Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation includes 2 parameters

  • Preliminary Report
  • Dihydropyrimidine Dehydrogenase Gene Mutation - Sequencing
Frequently Asked Questions

This test identifies mutations in the DPD (dihydropyrimidine dehydrogenase) gene, which affect the body’s ability to metabolize fluoropyrimidine-based chemotherapy drugs.

This test is recommended for:

  • Patients undergoing fluoropyrimidine (5-FU or capecitabine) chemotherapy.
  • Individuals with severe reactions to fluoropyrimidine-based drugs.

A blood or buccal swab sample is analyzed using PCR or DNA sequencing.

  • Positive Mutation: Increased risk of drug toxicity.
  • No Mutation: Normal drug metabolism expected.

Identifying DPD mutations helps adjust chemotherapy dosage and prevent severe drug toxicity.

Test code

8384

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Edta Whole BloodLavender Vacutainer2 ML

Specimen stability information

Edta Whole Blood

Collection instructions

Clinical History

Specimen rejection criteria

Test run frequency

Every Day TIME - 09:30

Turn around time

7 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d

CPT and Loinc codes

Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation

14500